Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Cancer Female 1

Interventions

durvalumab 1 abemaciclib 1 Saline Solution 1 Ketorolac Tromethamine 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Cancer Female × Ketorolac Tromethamine × Clear all

NCT03007381 2017-08-16

KANGAROO

Nova Scotia Health Authority

Phase 4 Withdrawn

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡